StockData
Geron Corp logo

Geron Corp (GERN) stock

GERNNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 4, 2026Score 2/30
$0.99−0.01 (-0.91%)

Close on Nov 18, 2026Market cap $636.63MP/E –Yield –

Geron operating income

Operating income is the profit from the core business after operating expenses such as R&D and selling costs, before interest and taxes.

Geron's operating income for the twelve months ending Jun 30, 2026 was -$51.77M. For fiscal 2025 it was -$68.59M. The highest annual figure on record is -$559.00K in fiscal 2015.

Annual operating income

PeriodPeriod endValueChange
FY2025Dec 31, 2025-$68.59M–
FY2024Dec 31, 2024-$173.73M–
FY2023Dec 31, 2023-$193.94M–
FY2022Dec 31, 2022-$138.55M–
FY2021Dec 31, 2021-$114.00M–
FY2020Dec 31, 2020-$76.91M–
FY2019Dec 31, 2019-$72.51M–
FY2018Dec 31, 2018-$31.07M–
FY2017Dec 31, 2017-$29.26M–
FY2016Dec 31, 2016-$30.65M–
FY2015Dec 31, 2015-$559.00K–
FY2014Dec 31, 2014-$36.31M–
FY2013Dec 31, 2013-$38.96M–
FY2012Dec 31, 2012-$71.76M–
FY2011Dec 31, 2011-$96.12M–
FY2010Dec 31, 2010-$111.17M–
FY2009Dec 31, 2009-$70.23M–

Quarterly operating income

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q2 FY2026Jun 30, 2026-$12.50M–
Q1 FY2026Mar 31, 2026$158.00K–
Q4 FY2025Dec 31, 2025-$25.54M–
Q3 FY2025Sep 30, 2025-$13.89M–
Q2 FY2025Jun 30, 2025-$12.45M–
Q1 FY2025Mar 31, 2025-$16.70M–
Q4 FY2024Dec 31, 2024-$20.05M–
Q3 FY2024Sep 30, 2024-$28.22M–
Q2 FY2024Jun 30, 2024-$69.33M–
Q1 FY2024Mar 31, 2024-$56.13M–
Q4 FY2023Dec 31, 2023-$54.29M–
Q3 FY2023Sep 30, 2023-$47.61M–
Q2 FY2023Jun 30, 2023-$51.95M–
Q1 FY2023Mar 31, 2023-$40.09M–
Q4 FY2022Dec 31, 2022-$41.95M–
Q3 FY2022Sep 30, 2022-$39.95M–
Q2 FY2022Jun 30, 2022-$27.98M–
Q1 FY2022Mar 31, 2022-$28.68M–
Q4 FY2021Dec 31, 2021-$30.98M–
Q3 FY2021Sep 30, 2021-$25.67M–
Q2 FY2021Jun 30, 2021-$28.89M–
Q1 FY2021Mar 31, 2021-$28.45M–
Q4 FY2020Dec 31, 2020-$23.27M–
Q3 FY2020Sep 30, 2020-$20.02M–
Q2 FY2020Jun 30, 2020-$16.76M–
Q1 FY2020Mar 31, 2020-$16.87M–
Q4 FY2019Dec 31, 2019-$30.01M–
Q3 FY2019Sep 30, 2019-$15.97M–
Q2 FY2019Jun 30, 2019-$15.22M–
Q1 FY2019Mar 31, 2019-$11.30M–
Q4 FY2018Dec 31, 2018-$9.59M–
Q3 FY2018Sep 30, 2018-$6.81M–
Q2 FY2018Jun 30, 2018-$7.24M–
Q1 FY2018Mar 31, 2018-$7.44M–
Q4 FY2017Dec 31, 2017-$7.79M–
Q3 FY2017Sep 30, 2017-$7.24M–
Q2 FY2017Jun 30, 2017-$6.73M–
Q1 FY2017Mar 31, 2017-$7.49M–
Q4 FY2016Dec 31, 2016-$8.78M–
Q3 FY2016Sep 30, 2016-$3.88M–

More Geron figures

See a number that looks wrong?